DABRA achieved a 98% lesion success rate in a 52-patient, single center study as reported by Elias Kassab, MD and Ashok Kondur, MD in the 2019 LINC Review.


Read more: https://www.leipzig-interventional-course.com/archive/linc-2019/linc-review/